Tingting Zhang

Academic Status: Postdoctoral Fellow

Previous Academic Training: PhD in Pharmaceutical Sciences (UBC), MSc (Simon Fraser University), MD (Capital University, China)

UBC Academic Department: Department of Medicine, Division of Neurology

Supervisor(s): Dr. Helen Tremlett, PhD

Project title(s): Disease progression in multiple sclerosis

Email: tingting.zhang@ubc.ca

Honors and Awards:

Postdoctoral Fellowship Award, Multiple Sclerosis Society of Canada (July 2014 – June 2016)
Travel award for the Alberta endMS Retreat 2013: All About Teamwork (September 2013)
Travel award, Canadian Society of Pharmacology and Therapeutics (July 2010)
Child & Family Research Institute Research Methodology Training Grant (July – August 2009)
Canadian Association for Population Therapeutics Studentship Award (August 2008)
University of British Columbia Entrance Scholarship (September 2007)
British Columbia Child and Youth Health Research Network Internship (May – September 2007)
British Columbia Medical Association Summer Research Scholarship (May – September 2006)
Simon Fraser University Graduate fellowship (September 2005 – April 2006)

Publications:

Peer-Reviewed Journal Papers

Zhang T, Shirani A, Zhao Y, Ehsanul Karim M, Gustafson P and Petkau J et al. Exposure to beta-interferon and onset of secondary progressive multiple sclerosis. European Journal of Neurology. 2015; 22(6):990-1000.
Zhang T, Smith A, Camp P and Carleton B. High use of health services in patients with suboptimal asthma drug regimens: a population-based assessment in British Columbia, Canada. Pharmacoepidemiology & Drug Safety. 2013 Jul;22(7):744-51.
Zhang T, Smith A, Camp P, MacLeod S and Carleton B. Prescription drug dispensing profiles for one million children: a population-based analysis. Eur J Clin Pharmacol. 2013 Mar;69(3):581-8.
Camp P, Zhang T, Smith A and Carleton B. The use of long-acting beta2-agonists as monotherapy in children and adults. Journal of Population Therapeutics and Clinical Pharmacology. 2013;20(1):e1-e12.
Chawla J, Seear M, Zhang T, Smith A and Carleton B. Fifty years of pediatric asthma in developed countries: how reliable are the basic data sources? Pediatric Pulmonology. 2012;47(3):211-9.
Zhang T, Carleton B, Smith A and Prosser R. The Added Burden of Comorbidity in Patients with Asthma. Journal of Asthma. 2009;46(10):1021-6.

Conference Proceedings

Jimenez-Mendez R, Zhang T, Smith A, and Carleton B. Changing asthma regimens from suboptimal to optimal: what are the impacts on health service use in patients with asthma? Pharmacoepidemiology and Drug Safety. 2011;20(S1):s253.
Zhang T, Smith A, Prosser R, and Carleton B. Asthma drug regimens and health service utilization: what impact do changes in the optimal use of medication have on children with asthma. Basic & Clinical Pharmacology & Toxicology. 2010;107(s1):s685.
Zhang T, Li Z, Smith A, Wang Y, Cao D and Carleton B. Pharmacoepidemiological studies in Chinese and Canadian children – lack of comprehensive data a major limitation. Basic & Clinical Pharmacology & Toxicology. 2010;107(s1):s686.
Zhang T, Prosser R, Smith A and Carleton B. Asthma drug regimens and health service utilization: how can we improve care? American Journal of Respiratory and Critical Care Medicine. 2010;181: A3125.
Zhang T, Carleton B, Smith A and Prosser R. Changing patterns of asthma patients’ medication regimens and health service utilization: a population-based study. Journal of Population Therapeutics and Clinical Pharmacology. 2008;15(3):e744.
Prosser B, Carleton B, Smith A and Zhang T. Prescription medication utilization in British Columbia’s pediatric population. Journal of Population Therapeutics and Clinical Pharmacology. 2008;15(3):e668.